| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP and CFO | Director | Chief Financial Officer +2 more
3 companies
Sam Eldessouky is EVP and CFO at BLCO, with reported holdings spanning 3 companies. Sam Eldessouky's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $9.1M at current prices.
Sam Eldessouky's largest disclosed position is in BLCO as EVP and CFO, worth about $7.9M. Net of sales, the BLCO filings show accumulation of 4,000 shares.
Sam Eldessouky has 40 Form 4 filings on record from January 2017 to August 2026, across 3 companies: EVP and CFO at Bausch + Lomb (BLCO), 2022–2026; Director at TE Connectivity (TEL), 2024–2025; EVP & Chief Financial Officer at Bausch Health Companies (BHC), 2017–2022.
The 66 reported transactions were 28 tax withholdings, 20 stock awards, 13 option or other derivative awards and 3 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $69K and 1 sale worth about $539K.
The only open-market purchase was 4,000 shares of BLCO at an average $17.13 on March 6, 2026, about $69K.
The only open-market sale was 17,000 shares of BHC at an average $31.68 on June 11, 2021, about $539K. Twelve months later BHC was down 75%.